Journal article
Effects of encainide and metabolizer phenotype on ventricular conduction during exercise
The American journal of cardiology, v 66(19), pp 1393-1396
1990
PMID: 2123075
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Genetic factors influence the extent of encainide metabolism. Approximately 93% of the Caucasian population extensively metabolize encainide to O-desmethyl encainide (ODE) and 3-methoxy-O-desmethyl encainide (MODE).
1 In extensive metabolizers, the steady-state plasma concentrations of ODE and MODE are higher than that of encainide during long-term therapy. In poor metabolizers, the metabolic profile is characterized by high concentrations of encainide, low concentrations of ODE, and absent MODE.
2
Encainide can produce marked prolongation of intraventricular conduction and this effect is rate-dependent.
3 Previous data indicate that ODE and MODE are more potent than encainide in this regard.
4 Consequently, the electropharmacologic effects of encainide would be expected to differ with respect to the genetically determined capacity to metabolize this drug. Thus, we postulated that extensive metabolizers of encainide would show more marked rate-dependent slowing of intraventricular conduction than would poor metabolizers. The present study determines if rate-dependent intraventricular conduction slowing could be demonstrated in patients receiving encainide during exercise-induced sinus tachycardia, and relates this effect to the genetic phenotype of encainide metabolism.
Metrics
Details
- Title
- Effects of encainide and metabolizer phenotype on ventricular conduction during exercise
- Creators
- Dean G. Karalis - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USACharles Nydegger - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USAR.Stephen Porter - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USAJoseph Carver - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USAIleana L. Pina - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USASteven P. Kutalek - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USAEric L. Michelson - From the Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Broad & Vine, Mail Stop 470, Philadelphia, Pennsylvania 19102-1192 USA
- Publication Details
- The American journal of cardiology, v 66(19), pp 1393-1396
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine
- Web of Science ID
- WOS:A1990EK56700028
- Scopus ID
- 2-s2.0-0025202975
- Other Identifier
- 991019340589004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Cardiac & Cardiovascular Systems